Page 1 of Clinical Trials for ( Reata Pharmaceuticals AND Inc. ) [SPONSOR-COLLABORATORS], 21 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis
Last Updated: February 17, 2009
Condition(s): Leptomeningeal Carcinomatosis
2
Completed
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
Last Updated: December 19, 2008
Condition(s): Glioma
3
Terminated
Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Last Updated: July 6, 2011
Condition(s): Pancreatic Neoplasms; Pancreatic Cancer
4
Withdrawn
Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma
Last Updated: December 7, 2007
Condition(s): Malignant Melanoma
5
Completed
Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy
Last Updated: July 6, 2011
Condition(s): Diabetic Nephropathy
6
Completed
Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
Last Updated: April 12, 2011
Condition(s): Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
7
Completed
RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies
Last Updated: December 19, 2008
Condition(s): Advanced Solid Tumors; Lymphoid Malignancies
8
Terminated
RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
Last Updated: June 27, 2011
Condition(s): Brain Metastases
9
Recruiting
Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
Last Updated: May 4, 2012
Condition(s): Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
10
Terminated
Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction
Last Updated: November 6, 2007
Condition(s): Liver Disease
11
Completed
A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl
Last Updated: March 30, 2012
Condition(s): Healthy Volunteers
12
Recruiting
Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function
Last Updated: May 4, 2012
Condition(s): Hepatic Impairment; Healthy
13
Not yet recruiting
An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers
Last Updated: May 14, 2012
Condition(s): Healthy Volunteers
14
Completed
A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects
Last Updated: December 31, 2011
Condition(s): Healthy
15
Recruiting
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Last Updated: May 4, 2012
Condition(s): Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
16
Recruiting
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Last Updated: May 21, 2012
Condition(s): Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
17
Not yet recruiting
A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
Last Updated: April 11, 2012
Condition(s): End-Stage Renal Disease; Type 2 Diabetes Mellitus
18
Completed
Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
Last Updated: June 23, 2011
Condition(s): Chronic Kidney Disease; Type 2 Diabetes; Diabetic Nephropathy
19
Recruiting
A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
Last Updated: February 8, 2012
Condition(s): Chronic Kidney Disease; Type 2 Diabetes
20
Completed
RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies
Last Updated: October 4, 2010
Condition(s): Lymphoid Malignancies; Solid Tumors

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Reata+Pharmaceuticals%2C+Inc.

Page 1 of Clinical Trials for ( Reata Pharmaceuticals AND Inc. ) [SPONSOR-COLLABORATORS], 21 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About